Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

A dronedarone hydrochloride tablet and preparation method thereof

A technology of dronedarone hydrochloride tablets and dronedarone hydrochloride, which is applied in the fields of pharmaceutical formulation, pill delivery, and medical preparations of non-active ingredients, etc., which can solve the problem of reduced absorbance, no solution proposed, and inability to fully simulate the human body Environmental problems, to achieve the effect of improving dissolution rate, convenient operation, and simple preparation process

Active Publication Date: 2019-04-26
SHANDONG NEWTIME PHARMA
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] The inventor considers that the prior art uses pH4.5 phosphate buffer as the dissolution medium, which cannot fully simulate the human body environment. Because dronedarone hydrochloride has the best solubility in the medium of pH4.5, the inventor intends to use water as the dissolution medium. Dissolution medium, preparation of rapidly dissolving dronedarone hydrochloride tablets in water
In order to improve the dissolution rate of dronedarone hydrochloride tablets, a large number of experiments have been carried out, and it was unexpectedly found that if a small amount of tap water remains in the dissolution cup during the dissolution test, the liquid medicine will become cloudy rapidly. In order to further confirm this phenomenon, the inventors mixed hydrochloric acid A small amount of tap water is added to the solution of dronedarone, the liquid becomes mixed, and the absorbance is significantly reduced. No solution has been proposed in the prior art

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A dronedarone hydrochloride tablet and preparation method thereof
  • A dronedarone hydrochloride tablet and preparation method thereof
  • A dronedarone hydrochloride tablet and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029]

[0030] Dronedarone hydrochloride, microcrystalline cellulose, crospovidone, and citric acid were all passed through a 100-mesh sieve, and the prescription amount was weighed, mixed evenly, added to the aqueous solution, granulated, and the prepared granules were mixed with magnesium stearate , Tablets.

Embodiment 2

[0032]

[0033] Dronedarone hydrochloride, lactose, croscarmellose sodium, and citric acid were all passed through a 100-mesh sieve, and the prescription amount was weighed, mixed evenly, added to the aqueous solution, granulated, and the prepared granules were mixed with magnesium stearate , Tablets.

Embodiment 3

[0035]

[0036] Dronedarone hydrochloride, microcrystalline cellulose, crospovidone, and citric acid were all passed through a 100-mesh sieve, and the prescription amount was weighed, mixed evenly, added to the aqueous solution, granulated, and the prepared granules were mixed with magnesium stearate , Tablets.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
Login to View More

Abstract

The invention discloses a dronedarone hydrochloride tablet and a preparation method thereof; the tablet contains citric acid and is prepared by the following method: mixing dronedarone hydrochloride, citric acid and pharmaceutically common auxiliary materials evenly, adding an aqueous solution, granulating, drying, adding a lubricant, mixing, and tabletting to obtain the product. Compared with the prior art, the dronedarone hydrochloride tablet has the dissolution rate of dronedarone hydrochloride in tap water significantly improved, and the in-vivo environment is better simulated; micronization, dispersion preparation and other complex operations are not needed, the preparation process is relatively simple, operations are convenient, addition of poloxamer and other surfactants are not needed, and the tablet is rapidly dissolved in a gastric juice.

Description

technical field [0001] The invention belongs to the technical field of pharmaceutical preparations, and in particular relates to a dronedarone hydrochloride tablet and a preparation method thereof. Background technique [0002] The chemical name of dronedarone is 2-n-butyl-3-[4-(3-di-n-butyl-aminopropoxy)benzoyl]-5-methylsulfonamide benzofuran, which is Sanox The latest drug developed by Felix-Zendibel for the treatment of cardiac arrhythmia. [0003] Dronedarone hydrochloride has very low solubility in aqueous media, especially its solubility is pH-dependent at room temperature, and has a maximum solubility in the range of pH 3 to 5, which is about 1-2 mg / ml, and is about 6 to 7 at pH The solubility becomes very low at pH=7, the solubility is only 10μg / ml at pH=7. [0004] Because of its dissolution characteristics, the solubility of dronedarone hydrochloride gradually decreases during the process of gradually increasing pH from the stomach to the intestinal tract, which ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/20A61K31/343A61K47/12A61P9/06
Inventor 赵志全郝贵周高西蒙陈美丽
Owner SHANDONG NEWTIME PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com